Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. - Suppr | 超能文献

Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

作者信息

Slayton R E, Blessing J A, Homesley H D

出版信息

Cancer Treat Rep. 1984 Dec;68(12):1513-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Cancer Treat Rep. 1984 Dec;68(12):1513-4.

2

Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2089-92.

3

Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.替尼泊苷治疗子宫颈鳞状细胞癌：妇科肿瘤学组的一项II期试验

Cancer Treat Rep. 1987 Sep;71(9):873-4.

4

Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.依托泊苷治疗晚期或复发性子宫内膜癌的II期试验：一项妇科肿瘤学组研究

Cancer Treat Rep. 1982 Aug;66(8):1669-71.

5

Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.

Cancer Treat Rep. 1987 Sep;71(9):869-70.

6

Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Cancer Treat Rep. 1983 Feb;67(2):197-8.

7

Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.口服依托泊苷治疗复发性或晚期子宫颈鳞状细胞癌：一项妇科肿瘤学组研究

Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097.

8

Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.氮烯醌治疗复发性宫颈鳞状细胞癌患者的II期临床试验：一项妇科肿瘤学组研究

Cancer Treat Rep. 1986 Sep;70(9):1127-8.

9

VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.

Cancer Treat Rep. 1978 May;62(5):843-4.

10

Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.美诺加 ril 治疗子宫颈鳞状细胞癌患者的 II 期试验：一项妇科肿瘤学组研究。

Gynecol Oncol. 1994 Feb;52(2):229-31. doi: 10.1006/gyno.1994.1036.

引用本文的文献

1

Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.妇科肿瘤学中的免疫检查点抑制剂：现状与展望

Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:166-188. doi: 10.1002/ijgo.70280.

2

A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.T7 噬菌体展示肽文库筛选发现 E2F-4 是依托泊苷结合蛋白。

Molecules. 2011 May 24;16(5):4278-94. doi: 10.3390/molecules16054278.

3

Chemotherapy for advanced or recurrent carcinoma of the cervix.晚期或复发性宫颈癌的化疗

Curr Oncol Rep. 2001 Jan;3(1):33-40. doi: 10.1007/s11912-001-0040-5.

4

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。

Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.